WW
GILD icon

Westshore Wealth’s Gilead Sciences GILD Stock Holding History

Westshore Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,272
Closed -$383K – 97
2021
Q4 		$383K Sell
5,272
-300
-5% -$20.7K 0.26% 51
2021
Q3 		$389K Sell
5,572
-2,746
-33% -$193K 0.31% 50
2021
Q2 		$573K Buy
8,318
+100
+1% +$6.68K 0.29% 56
2021
Q1 		$531K Buy
+8,218
New +$530K 0.3% 54
2019
Q4 		$320K Buy
+4,932
New +$321K 0.35% 59

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Westshore Wealth's GILD Position: Q1 2022 in Review

Westshore Wealth sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 5,272 shares — an estimated $383K sold.

Westshore Wealth first reported a position in GILD in Q4 2019 and held it in 5 quarters. The position peaked at $573K in Q2 2021. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

  • Westshore Wealth reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
  • Westshore Wealth sold 5,272 Gilead Sciences shares in Q1 2022, an estimated $383K.
  • Westshore Wealth first reported a position in Gilead Sciences in Q4 2019 and held it in 5 quarters.
  • Westshore Wealth's Gilead Sciences position peaked at $573K in Q2 2021.
  • 1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Westshore Wealth's 13F filing for Q1 2022, filed 10 May 2022.